Expand / Collapse search
Watch TV
☰

Quotes displayed in real-time or delayed by at least 15 minutes. Market data provided by Factset. Powered and implemented by FactSet Digital Solutions.  Legal Statement.

This material may not be published, broadcast, rewritten, or redistributed. ©2024 FOX News Network, LLC. All rights reserved. FAQ - New Privacy Policy

penumbra - PEN

PEN

Close Chg Chg %
240.61 -0.31 -0.13%

Pre-Market

240.30

-0.31 (0.13%)

Volume: 88.82K

Last Updated:

Dec 24, 2024, 12:59 PM EDT

Trade Now

Company Overview: penumbra - PEN

PEN Key Data

Open

$240.18

 Day Range

239.59 - 241.46

52 Week Range

148.16 - 277.30

 Market Cap

$9.23B

Shares Outstanding

38.38M

 Public Float

37.04M

Beta

0.51

 Rev. Per Employee

N/A

P/E Ratio

279.35

 EPS

$0.90

Yield

0.00%

 Dividend

N/A

EX-DIVIDEND DATE

SHORT INTEREST

N/A

AVERAGE VOLUME

324.10K

  

PEN Performance

1 Week
 
 -0.90%
 
1 Month
 
 -1.54%
 
3 Months
 
 25.48%
 
1 Year
 
 -7.05%
 
5 Years
 
 46.47%
 

PEN Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 19
Full Ratings ➔

About penumbra - PEN

Penumbra, Inc. engages in the design, development, manufacture, and marketing of innovative medical devices. It offers neurovascular thrombectomy and embolization and access technologies, neurosurgical tools, Penumbra LANTERN Delivery Microcatheter, and Penumbra Occlusion Device (POD) system. The company was founded by Arani Bose and Adam Elsesser on June 21, 2004, and is headquartered in Alameda, CA.

PEN At a Glance

Penumbra, Inc.
One Penumbra Place
Alameda, California 94502
Phone 1-510-748-3200 Revenue 1.06B
Industry Medical Specialties Net Income 90.95M
Sector Health Technology 2023 Sales Growth 24.953%
Fiscal Year-end 12 / 2024 Employees 4,200
View SEC Filings

PEN Valuation

P/E Current 279.352
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) 108.455
Price to Sales Ratio 9.319
Price to Book Ratio 8.253
Price to Cash Flow Ratio 101.348
Enterprise Value to EBITDA 80.162
Enterprise Value to Sales 9.267
Total Debt to Enterprise Value 0.024

PEN Efficiency

Revenue/Employee 252,029.048
Income Per Employee 21,655.714
Receivables Turnover 5.246
Total Asset Turnover 0.723

PEN Liquidity

Current Ratio 6.056
Quick Ratio 3.489
Cash Ratio 1.913

PEN Profitability

Gross Margin 63.55
Operating Margin 8.669
Pretax Margin 7.525
Net Margin 8.593
Return on Assets 6.214
Return on Equity 8.353
Return on Total Capital 6.436
Return on Invested Capital 6.936

PEN Capital Structure

Total Debt to Total Equity 19.877
Total Debt to Total Capital 16.581
Total Debt to Total Assets 15.058
Long-Term Debt to Equity 18.738
Long-Term Debt to Total Capital 15.631
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Penumbra - PEN

Collapse All in section
All values USD millions. 2020 2021 2022 2023 5-year trend
Sales/Revenue
560.41M 747.59M 847.13M 1.06B
Sales Growth
+2.38% +33.40% +13.32% +24.95%
Cost of Goods Sold (COGS) incl D&A
223.04M 274.83M 320.84M 385.83M
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
15.68M 19.49M 27.57M 30.61M
Depreciation
14.61M 16.61M 18.39M 20.39M
Amortization of Intangibles
1.07M 2.88M 9.18M 10.21M
COGS Growth
+26.56% +23.22% +16.74% +20.25%
Gross Income
337.37M 472.76M 526.29M 672.69M
Gross Income Growth
-9.11% +40.13% +11.32% +27.82%
Gross Profit Margin
+60.20% +63.24% +62.13% +63.55%
2020 2021 2022 2023 5-year trend
SG&A Expense
373.81M 480.26M 520.21M 580.93M
Research & Development
87.55M 104.55M 79.41M 84.42M
Other SG&A
286.26M 375.71M 440.80M 496.50M
SGA Growth
+15.48% +28.48% +8.32% +11.67%
Other Operating Expense
- - - -
-
Unusual Expense
- - 2.50M 18.21M
-
EBIT after Unusual Expense
(38.94M) (7.50M) 6.08M 73.55M
Non Operating Income/Expense
924.00K (3.00M) (2.19M) 7.84M
Non-Operating Interest Income
1.27M 938.00K 137.00K 6.83M
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
- - - 1.74M
-
Interest Expense Growth
- - - -
-
Gross Interest Expense
- - - 1.74M
-
Interest Capitalized
- - - -
-
Pretax Income
(38.02M) (10.50M) 3.89M 79.65M
Pretax Income Growth
-175.83% +72.38% +137.06% +1,946.51%
Pretax Margin
-6.78% -1.40% +0.46% +7.52%
Income Tax
(18.76M) (13.13M) 5.89M (11.30M)
Income Tax - Current - Domestic
55.00K 483.00K 3.10M 8.93M
Income Tax - Current - Foreign
907.00K 1.34M 1.73M 4.89M
Income Tax - Deferred - Domestic
(19.62M) (14.83M) 1.54M (23.87M)
Income Tax - Deferred - Foreign
(106.00K) (124.00K) (476.00K) (1.25M)
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
(19.26M) 2.62M (2.00M) 90.95M
Minority Interest Expense
- - (3.56M) (2.66M)
-
Net Income
(15.70M) 5.28M (2.00M) 90.95M
Net Income Growth
-132.40% +133.65% -137.89% +4,643.16%
Net Margin Growth
-2.80% +0.71% -0.24% +8.59%
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
(15.70M) 5.28M (2.00M) 90.95M
Preferred Dividends
- - - -
-
Net Income Available to Common
(15.70M) 5.28M (2.00M) 90.95M
EPS (Basic)
-0.439 0.1437 -0.0529 2.3685
EPS (Basic) Growth
-131.48% +132.73% -136.81% +4,577.32%
Basic Shares Outstanding
35.77M 36.76M 37.84M 38.40M
EPS (Diluted)
-0.439 0.1395 -0.0529 2.3193
EPS (Diluted) Growth
-132.85% +131.78% -137.92% +4,484.31%
Diluted Shares Outstanding
35.77M 37.88M 37.84M 39.22M
EBITDA
(20.76M) 11.99M 33.66M 122.37M
EBITDA Growth
-137.53% +157.74% +180.72% +263.60%
EBITDA Margin
-3.71% +1.60% +3.97% +11.56%

Snapshot

Average Recommendation OVERWEIGHT Average Target Price 257.313
Number of Ratings 19 Current Quarters Estimate 0.897
FY Report Date 12 / 2024 Current Year's Estimate 2.794
Last Quarter’s Earnings 0.85 Median PE on CY Estimate N/A
Year Ago Earnings 2.09 Next Fiscal Year Estimate 3.804
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 17 14 18 18
Mean Estimate 0.90 0.75 2.79 3.80
High Estimates 1.08 1.05 2.99 4.44
Low Estimate 0.80 0.63 2.70 3.42
Coefficient of Variance 6.80 15.35 2.15 6.02

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 12 10 10
OVERWEIGHT 1 1 2
HOLD 5 6 6
UNDERWEIGHT 1 1 0
SELL 0 0 0
MEAN Overweight Overweight Overweight

Insider Actions for Penumbra - PEN

Date Name Shares Transaction Value
Oct 4, 2024 Harpreet S. Grewal Director 8,697 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $190.83 per share 1,659,648.51
Oct 4, 2024 Johanna Roberts EVP, Gen. Counsel & Secretary 60,488 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $194.44 per share 11,761,286.72
Oct 4, 2024 Don W. Kassing Director 835 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $193.93 per share 161,931.55
Oct 4, 2024 Johanna Roberts EVP, Gen. Counsel & Secretary 60,491 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $193.73 per share 11,718,921.43
Oct 4, 2024 Johanna Roberts EVP, Gen. Counsel & Secretary 60,503 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $192.51 per share 11,647,432.53
Oct 4, 2024 Johanna Roberts EVP, Gen. Counsel & Secretary 60,551 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $191.65 per share 11,604,599.15
Oct 4, 2024 Johanna Roberts EVP, Gen. Counsel & Secretary 60,735 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $190.72 per share 11,583,379.20
Oct 4, 2024 Johanna Roberts EVP, Gen. Counsel & Secretary 61,067 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $187.32 per share 11,439,070.44
Oct 4, 2024 Johanna Roberts EVP, Gen. Counsel & Secretary 61,007 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $188.51 per share 11,500,429.57
Oct 4, 2024 Johanna Roberts EVP, Gen. Counsel & Secretary 60,934 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $189.67 per share 11,557,351.78
May 23, 2024 Adam Elsesser CEO and President; Director 949,863 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $200.62 per share 190,561,515.06
May 23, 2024 Adam Elsesser CEO and President; Director 943,544 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $201.16 per share 189,803,311.04
May 23, 2024 Adam Elsesser CEO and President; Director 942,865 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $202.46 per share 190,892,447.90
May 23, 2024 Adam Elsesser CEO and President; Director 942,582 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $203.35 per share 191,674,049.70
May 16, 2024 Johanna Roberts EVP, Gen. Counsel & Secretary 63,488 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $214.43 per share 13,613,731.84
May 9, 2024 Arani Bose Director N/A Bona fide gift 0.00
Mar 20, 2024 Lambert Shiu Chief Accounting Officer 20,539 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 20, 2024 Maggie S. Yuen Chief Financial Officer 13,129 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $222.15 per share 2,916,607.35
Mar 20, 2024 Maggie S. Yuen Chief Financial Officer 13,322 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 20, 2024 Lambert Shiu Chief Accounting Officer 20,307 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $222.15 per share 4,511,200.05

Penumbra in the News